Articles by Jim Hall - BioPharm International

Articles by Jim Hall

As the industry focuses on late-stage deals, Big Pharma takes on the risks of compounds in preclinical development.
Oct 1, 2004
By: Jim Hall

More than half the deals made by pharma are with companies based in the US, 28 percent in Europe, and 15 percent Japan.